In silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19 DM Teli, MB Shah, MT Chhabria Frontiers in molecular biosciences 7, 599079, 2021 | 112 | 2021 |
Tirzepatide, a new era of dual-targeted treatment for diabetes and obesity: a mini-review VP Chavda, J Ajabiya, D Teli, J Bojarska, V Apostolopoulos Molecules 27 (13), 4315, 2022 | 102 | 2022 |
Identification of potential Mpro inhibitors for the treatment of COVID-19 by using systematic virtual screening approach AM Kanhed, DV Patel, DM Teli, NR Patel, MT Chhabria, MR Yadav Molecular diversity 25, 383-401, 2021 | 65 | 2021 |
Novel carbazole-stilbene hybrids as multifunctional anti-Alzheimer agents DV Patel, NR Patel, AM Kanhed, DM Teli, KB Patel, PD Joshi, SP Patel, ... Bioorganic Chemistry 101, 103977, 2020 | 29 | 2020 |
Molnupiravir: A versatile prodrug against SARS-CoV-2 variants D Teli, P Balar, K Patel, A Sharma, V Chavda, L Vora Metabolites 13 (2), 309, 2023 | 24 | 2023 |
Propolis and their active constituents for chronic diseases VP Chavda, AZ Chaudhari, D Teli, P Balar, L Vora Biomedicines 11 (2), 259, 2023 | 19 | 2023 |
Further studies on triazinoindoles as potential novel multitarget-directed anti-alzheimer’s agents DV Patel, NR Patel, AM Kanhed, DM Teli, KB Patel, PM Gandhi, SP Patel, ... ACS Chemical Neuroscience 11 (21), 3557-3574, 2020 | 19 | 2020 |
Potential anti-SARS-CoV-2 prodrugs activated by phosphorylation and their role in the aged population VP Chavda, D Teli, PC Balar, D Vaghela, HK Solanki, A Vaishnav, L Vora Molecules 28 (5), 2332, 2023 | 14 | 2023 |
Antibody–biopolymer conjugates in oncology: a review VP Chavda, PC Balar, D Teli, M Davidson, J Bojarska, V Apostolopoulos Molecules 28 (6), 2605, 2023 | 13 | 2023 |
Carbazole-based semicarbazones and hydrazones as multifunctional anti-Alzheimer agents KB Patel, DV Patel, NR Patel, AM Kanhed, DM Teli, B Gandhi, BS Shah, ... Journal of Biomolecular Structure and Dynamics 40 (20), 10278-10299, 2022 | 11 | 2022 |
Fragment-based design of SARS-CoV-2 Mpro inhibitors DM Teli, B Patel, MT Chhabria Structural Chemistry 33 (6), 2155-2168, 2022 | 9 | 2022 |
Identification of potential Mpro inhibitors for the treatment of COVID-19 by targeted covalent inhibition: An in silico approach DV Patel, DM Teli, AM Kanhed, NR Patel, BS Shah, AK Vora, ... International Journal of Quantitative Structure-Property Relationships …, 2021 | 4 | 2021 |
Anti‐Epileptic Drug‐Lipid Conjugates for Delivery to the Brain: In Silico ADMET Prediction, Molecular Docking and Molecular Dynamics Simulations M Athalye, D Teli, A Sharma, M Patel ChemistrySelect 8 (34), e202301701, 2023 | 2 | 2023 |
History of Nanoparticles KL Jetha, A Vyas, D Teli, A Chaudhari, R Satasiya, V Patel, S Soni, ... Nanocarrier Vaccines: Biopharmaceutics‐Based Fast Track Development, 1-23, 2024 | 1 | 2024 |
Design, synthesis and biological evaluation of novel DPP-IV inhibitors C Karelia, K Parmar, D Teli, M Chhabria J Indian Chem Soc 97 (8), 1227-1235, 2020 | 1 | 2020 |
Composition of Nanoparticles A Chaudhari, P Vadodariya, A Vyas, D Patel, D Teli Nanocarrier Vaccines: Biopharmaceutics‐Based Fast Track Development, 25-62, 2024 | | 2024 |
Dietary Supplements and Nutraceuticals Against the Variants of SARS-CoV-2 AZ Chaudhari, D Teli, PC Balar, J Gandhi, VP Chavda SARS-CoV-2 Variants and Global Population Vulnerability, 357-390, 2024 | | 2024 |
Drug Repurposing for COVID-19 and Fast Track New Drug Discovery for Emerging SARS-CoV-2 Variants D Teli, AZ Chaudhari, D Patel, M Chhabria SARS-CoV-2 Variants and Global Population Vulnerability, 163-207, 2024 | | 2024 |
Nature Meets Technology: Harnessing Nanotechnology to Unleash the Power of Phytochemicals D Teli, R Satasia, V Patel, R Nair, R Khatri, D Gala, PC Balar, K Patel, ... Clinical Traditional Medicine and Pharmacology, 200139, 2024 | | 2024 |
Propolis in the management of cardiovascular disease VP Chavda, S Vuppu, PC Balar, T Mishra, R Bezbaruah, D Teli, N Sharma, ... International Journal of Biological Macromolecules, 131219, 2024 | | 2024 |